Association of serum uric acid levels with COVID-19 severity

BMC Endocrine Disorders

Table 4 Incidence rate ratio of COVID-19 patients

	UA Group	Severe COVID-19	Person-Days	Incidence Rate	Incidence Rate Ratio (95% CI)
Total	High-UA (n = 45)	10 (22.2%)	323	0.031	0.84 (0.36, 1.98)
Total	Low-UA (n = 45)	11 (24.4%)	423	0.026	0.84 (0.36, 1.98)
Male	High-UA (n = 19)	3 (15.8%)	152	0.020	4.05 (1.11, 14.72)
Male	Low-UA (n = 20)	10 (55.0%)	123	0.081	4.05 (1.11, 14.72)
Female	High-UA (n = 25)	6 (24.0%)	257	0.023	0.26 (0.05, 1.29)
Female	Low-UA (n = 26)	2 (7.7%)	313	0.006	0.26 (0.05, 1.29)

Notes: the cut-off point of total patients between high-UA and low-UA is 277 μmol /L (Median)
the cut-off point of male patients between high-UA and low-UA is 334 μmol /L (Median)
the cut-off point of female patients between high-UA and low-UA is 252 μmol /L (Median)
Days referred to the time from admission to the severe period
One patient was not analyzed because he was severe type at admission

ISSN: 1472-6823